Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Lambert

Showing results (291-300 of 301) with videos related to

Pageof 31
Sort By:
Clinical and Experimental Immunology|September 1, 1993
Successful primate immunization with peptides conjugated to purified protein derivative or mycobacterial heat shock proteins in the absence of adjuvantsR Perraut, A R Lussow, S Gavoille, et al.
European Journal of Immunology|June 1, 1992
Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin primingC Barrios, A R Lussow, J Van Embden, et al.
European Journal of Immunology|October 1, 1991
Mycobacterial heat-shock proteins as carrier moleculesA R Lussow, C Barrios, J van Embden, et al.
Vaccine|January 16, 2010
The second Geneva Consensus: Recommendations for novel live TB vaccinesK B Walker, M J Brennan, M M Ho, et al.
The American Journal of Tropical Medicine and Hygiene|March 1, 1987
Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 childrenG Del Giudice, H D Engers, C Tougne, et al.
Contributions to Microbiology and Immunology|January 1, 1983
Immunological pathogenesis of experimental glomerulonephritis induced by some infectious and toxic agentsG J Fournié, J Lulé, M Gayral-Taminh, et al.
Bulletin of the World Health Organization|January 1, 1972
Virus-associated immunopathology: animal models and implications for human disease. 2. Cell-mediated immunity, autoimmune diseases, genetics, and implications for clinical researchA C Allison, W I Beveridge, W C Cockburn, et al.
Bulletin of the World Health Organization|January 1, 1972
Virus-associated immunopathology: animal models and implications for human disease. 1. Effects of viruses on the immune system, immune-complex diseases, and antibody-mediated immunologic injuryA C Allison, W I Beveridge, W C Cockburn, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 8, 2020
Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trialO Chatzis, G Blanchard-Rohner, L Mondoulet, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 22, 1998
Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and ImmunologyJ Bousquet, R Lockey, H J Malling, et al.
Pageof 31

Showing results (291-300 of 301) with videos related to

Sort By:
Pageof 31
Clinical and Experimental Immunology|September 1, 1993
Successful primate immunization with peptides conjugated to purified protein derivative or mycobacterial heat shock proteins in the absence of adjuvantsR Perraut, A R Lussow, S Gavoille, et al.
European Journal of Immunology|June 1, 1992
Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin primingC Barrios, A R Lussow, J Van Embden, et al.
European Journal of Immunology|October 1, 1991
Mycobacterial heat-shock proteins as carrier moleculesA R Lussow, C Barrios, J van Embden, et al.
Vaccine|January 16, 2010
The second Geneva Consensus: Recommendations for novel live TB vaccinesK B Walker, M J Brennan, M M Ho, et al.
The American Journal of Tropical Medicine and Hygiene|March 1, 1987
Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 childrenG Del Giudice, H D Engers, C Tougne, et al.
Contributions to Microbiology and Immunology|January 1, 1983
Immunological pathogenesis of experimental glomerulonephritis induced by some infectious and toxic agentsG J Fournié, J Lulé, M Gayral-Taminh, et al.
Bulletin of the World Health Organization|January 1, 1972
Virus-associated immunopathology: animal models and implications for human disease. 2. Cell-mediated immunity, autoimmune diseases, genetics, and implications for clinical researchA C Allison, W I Beveridge, W C Cockburn, et al.
Bulletin of the World Health Organization|January 1, 1972
Virus-associated immunopathology: animal models and implications for human disease. 1. Effects of viruses on the immune system, immune-complex diseases, and antibody-mediated immunologic injuryA C Allison, W I Beveridge, W C Cockburn, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 8, 2020
Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trialO Chatzis, G Blanchard-Rohner, L Mondoulet, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 22, 1998
Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and ImmunologyJ Bousquet, R Lockey, H J Malling, et al.
Pageof 31